MAPT and Alzheimer disease: In patients with documented MCI, positive amyloid biomarker testing, and positive tau neurofibrillary tangle biomarker testing, we suggest categorization as “epileptic prodromal AD,” a term previously proposed by Cretin et al. (32) and again corresponding with existing biopatholic research terminology.